Related Experiment Video
Updated: May 9, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Transcatheter Aortic Valve Replacement in Systemic Sclerosis: A Case Series and Review of Short- and Long-Term
Chris T Derk1, Ahmadreza Badali2, Esra Mehmetoglu3
1Department of Internal Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia, USA.
Objectives:
A higher frequency of valvular heart disease is seen among Systemic Sclerosis (SSc) patients. Advanced aortic valve stenosis leads to significant morbidity in these patients with multiple other comorbidities. In this study, we aim to define the short- and long-term outcomes of transcatheter aortic valve replacement (TAVR) procedures in SSc patients.
Methods:
We undertook a retrospective chart review of all patients with SSc who underwent a TAVR procedure at our institution over a defined 11-year period. Demographics as well as short- and long-term outcomes were identified.
Results:
Fourteen SSc patients underwent a TAVR procedure between 2012 and 2023. They were predominantly older Caucasian female patients with limited cutaneous SSc (lcSSc) with advanced aortic stenosis. Only one patient had a readmission within 30 days due to post-op heart failure and subsequently had to have the TAVR reversed to a SAVR.
Conclusions:
TAVR is a well-tolerated procedure in SSc patients with advanced aortic stenosis and multiple comorbidities.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Atherosclerosis III: Management
Aortic Regurgitation III: Medical Management
Rheumatic Heart Disease I: Introduction
Mitral Stenosis III: Medical Management